Stem Cell Clinic

R3 Stem Cell Clinics Expand to Southern California, Now Offering Procedures in Beverly Hills

By Stem Cell Medicine

Los Angeles, California (PRWEB) June 30, 2014

R3 Stem Cell has expanded to Southern California, and is now offering procedures in Beverly Hills to patients. The company has partnered with Beverly Hills Orthopedic Institute to now offer three different types of stem cell procedures to patients for all types of degenerative arthritis, tendonitis and ligament injuries. For more information and patient scheduling, call (310) 438-5343.

R3 Stem Cell works with medical practices nationwide to offer stem cell therapy for all types of musculoskeletal conditions. The three types of procedures offered are bone marrow derived stem cell therapy, amniotic derived stem cell therapy and platelet rich plasma therapy.

Said R3 CEO Bob Maguire, Patients are now benefiting from stem cell procedures by delaying or avoiding the need for joint replacement due to the amazing pain relief and regeneration possible with the procedures. We are very excited to be expanding into Southern California to help more patients and have the opportunity to work with a highly respected physician like Dr. Raj.

The R3 Stem Cell partnership with Beverly Hills Orthopedic Institute brings the stem cell therapy to patients with treatment from Dr. Raj. As a Double Board Certified orthopedic doctor and a WebMD medical expert, Dr. Raj has pioneered the clinical use of stem cell therapy for patients.

Treatment is offered for athletes, grandparents, weekend warriors, manual laborers, students, essentially the whole spectrum of individuals who can benefit from regeneration of soft tissue or bony injury. This includes degenerative arthritis, rotator cuff injury, plantar fasciitis, Achilles or knee tendonitis, tennis elbow and additional indications such as chronic wounds from diabetes.

Dr. Raj stated The partnership with R3 Stem Cell is great because of the stem cell procedure options I now have available for patients along with the research protocols. It will only improve patient outcomes dramatically.

R3 Stem Cell works with medical practices nationwide on instituting regenerative medicine into the practice. Several procedure options are included such as bone marrow, amniotic and PRP therapy. In addition, research protocols and education come with the partnership.

For individuals interested in obtaining stem cell therapy for any type of arthritis, tendonitis, or ligament injury in the Los Angeles or Beverly Hills area, simply call (310) 438-5343.

See the original post:
R3 Stem Cell Clinics Expand to Southern California, Now Offering Procedures in Beverly Hills

Her own stem cells saved her from hip replacement

By Stem Cell Medicine

Apollo Health City team did autologous stem cell procedure to save both the hip joints

Hyderabad, June 30:

A team of doctors from a city hospital have harvested stem cells of a person using bone morrow from the pelvis area to replace some dead tissues in the hip. In this process, they saved the patient from undergoing a hip replacement.

The Apollo Health City team, headed by orthopaedic specialist Paripati Sharat Kumar, diagnosed a 39-year-old woman to be suffering from Avascular Necrosis, making her writhe with pain in her two hip joints. Her condition would require undergoing a replacement of hips.

After assessing her condition, the team has decided to go for autologous stem cell procedure (where donor and the receiver is the same person) to save both the hip joints.

The minimally invasive procedure involved taking bone marrow aspirate from the patients pelvis. Stem cells were harvested from the aspirate, through a process that takes about 15 minutes. Stems cells were planted in the area of damage under fluoroscopy control following core decompression, Sharat Kumar said here in a statementon Monday.

He felt that autologous stem cell treatments could edge out joint replacement procedures to a large extent in days to come. The scope of this procedure in orthopaedics and sports medicine is enormous. This could be extended to indications include osteoarthritis of knee, shoulder, hip, elbows, ankle and spine, he said.

(This article was published on June 30, 2014)

Link:
Her own stem cells saved her from hip replacement

Stem cells may be more widespread and with greater potential than previously believed

By Stem Cell Medical Center

PUBLIC RELEASE DATE:

30-Jun-2014

Contact: Cody Mooneyhan cmooneyhan@faseb.org 301-634-7104 Federation of American Societies for Experimental Biology

With the plethora of research and published studies on stem cells over the last decade, many would say that the definition of stem cells is well established and commonly agreed upon. However, a new review article appearing in the July 2014 issue of The FASEB Journal , suggests that scientists have only scratched the surface of understanding the nature, physiology and location of these cells. Specifically, the report suggests that embryonic and induced pluripotent stem cells may not be the only source from which all three germ layers in the human body (nerves, liver or heart and blood vessels) can develop. The review article suggests that adult pluripotent stem cells are located throughout the body and are able to become every tissue, provided these cells receive the right instructions.

"This study highlights the mutual role of stem cells both for regeneration and in tumor growth by featuring two sides of the same coin: stems cells in cancer and regenerative medicine," said Eckhard Alt, M.D., Ph.D., the article's lead author from the Center for Stem Cell and Developmental Biology at the University of Texas MD Anderson Cancer Center in Houston, Texas. "Our workprovides novel insight on why and how mature has provided us with one universal type of stem cell that is equally distributed throughout the whole body, every organ and every tissue. Small early pluripotent stem cells are ubiquitously located in and around the blood vessels throughout the whole body and serve as a reserve army for regeneration."

In the review, Alt and colleagues suggest that small early pluripotent stem cells are able to replace any kind of tissue in the body--independent of where they comes from in the body--given that these cells receive the correct instructions. When researchers extract these cells from fat tissue, concentrated them and then injected them into diseased or injured tissue, they delivered beneficial outcomes for ailments such as heart failure, osteoarthritis, non-healing wounds, soft tissue defects, muscle, bone and tendon injuries and neurodegenerative diseases. The review also discusses how this is basically the same process that occurs in tumors, except that instead of healing or regenerating tissue, the cells work toward building a tumor. Better understanding and manipulating how these cells communicate not only will open new therapies that heal injury (heart failure, wounds, etc.), but will allow researchers to stop many cancers before they become life-threatening.

"This article suggests that the countless hours spent researching cancer and progenitor cells are finally coming to a head," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "As the intersection between cancer and stem cell research becomes closer and clearer, all of today's medical treatments will begin to look as crude as Civil War medicine."

###

Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is among the most cited biology journals worldwide according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.

FASEB is composed of 26 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Continue reading here:
Stem cells may be more widespread and with greater potential than previously believed

Saving Sabrina: double umbilical cord transplant

By Stem Cell Doctors

FRESNO, Calif. (KFSN) --

From playing Uno to dancing with her sibling, you would never have guessed that just last year 15-year-old Sabrina Couillard was fighting for her life.

"I was getting really skinny. I was getting bruises everywhere," Couillard told ABC30.

She was diagnosed with leukemia.

"I just broke down (and) cried," Sabrina's mom, Marta Gonzalez told ABC30.

Her only hope for a cure was a bone marrow transplant, but doctors couldn't find a match from a family member. That's when her doctor, Kamar Godder, turned to an alternative stem cell source: the umbilical cord.

"We knew that when you give it to somebody who is heavier, a heavier child or adult it will not quote unquote take," Kamar Godder, MD, Pediatric, Hematologist/Oncologist, Miami Children's Hospital, told ABC30.

Couillard's doctor gave her a double umbilical cord transplant.

"Initially the thought was just to give more of (the) cells," Dr. Godder explained. "Eventually only one will take over, that's the interesting thing."

Dr. Godder says that earlier studies have shown that cell count is the most important factor after degree of match for succesful transplant.

Go here to read the rest:
Saving Sabrina: double umbilical cord transplant

Special birthday present: Stem cell donor returns to Goltry

By Stem Cell Doctors

GOLTRY, Okla. A Goltry-area woman is back on Oklahoma soil after traveling to Milwaukee to give her brother a special birthday present.

Jeni Sumner was the only match among family members tested to donate stem cells to her younger brother, who was diagnosed with acute myelogenous leukemia last year.

Ed Dees cancer went into remission last October but returned earlier this year. Sumner said Dees doctors felt a stem cell transplant would be the best treatment.

Sumner spoke by phone about the events of the past week, as she prepared to return to Oklahoma on Thursday morning.

The transplant began at 2:07 p.m. Tuesday Dees birthday and took about an hour, she said.

We had a little birthday party for him and then he got my present, Sumner said.

Prior to the transplant, Dee went through chemotherapy and had a conditioning treatment, which Sumner said entailed the doctors wiping out his immune system and blood levels.

Sumner had to give herself injections over four days to make her bone marrow produce more stem cells and push them into her blood.

Those went really well, she said.

The stem cell retrieval process was on Monday.

View original post here:
Special birthday present: Stem cell donor returns to Goltry

New Stem Cell Production Method Could Clear Way for Anticancer Gene Therapy

By Stem Cell Medicine

Durham, NC (PRWEB) June 27, 2014

A new study released today in STEM CELLS Translational Medicine suggests a new way to produce endothelial progenitor cells in quantities large enough to be feasible for use in developing new cancer treatments.

Endothelial progenitor cells (EPCs) are rare stem cells that circulate in the blood with the ability to differentiate into the cells that make up the lining of blood vessels. With an intrinsic ability to home to tumors, researchers have focused on them as a way to deliver gene therapy straight to the cancer. However, the challenge has been to collect enough EPCs for this use.

This new study, by researchers at the Institute of Bioengineering and Nanotechnology, National University of Singapore and Zhejiang University led by Shu Wang, Ph.D., explored whether human induced pluripotent stem cells (iPSCs) could provide the answer. iPSCs, generated from adult cells, can propagate indefinitely and give rise to every other cell type in the body, much like human embryonic stem cells, which are considered the gold standard for stem cell therapy.

However, human iPS cells can be generated relatively easily through reprogramming, a procedure that circumvents the bioethical controversies associated with deriving embryonic stem cells from human embryos, Dr. Wang said.

After inducing human iPS cells to differentiate into the EPCs, the research team compared the stability and reliability of the induced EPCs with regular EPCs by injecting them into mice with breast cancer that had metastasized (traveled) to the lungs. The results showed that their induced EPCs retained the intrinsic ability to home to tumors, just as regular EPCs do. They also did not promote tumor growth or metastasis.

We next tested the induced EPCs therapeutic potential by infusing them with an anticancer gene and injecting them into the mice, Dr. Wang said. The results indicated that the tumors were reduced and the animals survival rates increased.

Since this approach may use patient's own cells to prepare cellular therapeutics and is based on non-toxic immunotherapy, it holds potential for translation to clinical application and may be particularly valuable as a new type of anti-metastatic cancer therapy.

With the increasing potential of using EPCs as cancer therapeutics, it is important to have a reliable and stable supply of human EPCs, said Anthony Atala, M.D., editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. This study demonstrates the feasibility of generating EPs from early-passage human iPS cells.

###

Link:
New Stem Cell Production Method Could Clear Way for Anticancer Gene Therapy

Regenerative Medicine Solutions Acquires Advanced Healthcare Partners

By Stem Cell Medicine

Tampa, FL (PRWEB) June 27, 2014

Furthering its goal to restore quality of life to patients with little or no hope of medical improvement, Regenerative Medicine Solutions (RMS) announced today that it has entered into an agreement to acquire Advanced Healthcare Partners (AHP). The strategy behind the business move was the realignment of resources, and the innovative use of stem cells to treat an array of medical conditions under one roof. AHP was a leading healthcare management and consulting company, which owned and operated the Lung Institute.

We are now ready to continue growing the Lung Institute to be the world leader in the care of patients suffering from lung disease by providing the best option for their treatment, said Jimmy St. Louis, Chief Executive Officer of RMS. In order to accomplish this mission, we needed to combine all of our teammates and resources together to focus on one company and one mission, RMS.

As a leader in regenerative medicine, the Lung Institute utilizes stem cells from the patients own body to treat lung disease. These autologous cells work to promote the repair and regeneration of previously damaged lung tissue. RMS is a global provider of stem cell therapy for medical conditions in areas of the body other than the lung.

All AHP and Lung Institute 31 employees are now considered employees of RMS, added St. Louis. With everyone together as one cohesive team, we have tripled our number. We are one team, with one goal: utilization of regenerative medicine to improve the quality of life of our patients from COPD to Crohns disease and beyond.

Together, RMS and the Lung Institute will offer patients access to better care with a staff dedicated to one goal: Improving quality of life in patients. Financial terms of the agreement were not disclosed. RMS has facilities in Tampa and Lima, Peru.

About Regenerative Medicine Solutions Regenerative Medicine Solutions (RMS) is a leading global provider of innovative regenerative technologies in order to treat an array of debilitating medical conditions. Committed to an individualized patient-centric approach, RMS consistently provides the highest quality of care while producing positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, RMS is changing lives. For more information, visit our website at myregenmed.com, like us on Facebook, or follow us on Twitter or call us today at 1-855-469-5864.

About Lung Institute Located in Tampa, Florida, the Lung Institute is changing the lives of hundreds of people across the world through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 1-855-4MY-LUNG.

Original post:
Regenerative Medicine Solutions Acquires Advanced Healthcare Partners

→←